expertreviewby [‘mediPr]

Hong Kong · Sponsored

Advancements in Ovarian Cancer Treatment: Insights from ASCO 2024

29 Aug 2024Oncology

This content is sponsored. It is intended for healthcare professionals only.

Ovarian cancer is the 8th most common cancer in women globally, with an age-standardised incidence rate of 6.7 per 100,000 in 2022.

Advancements in Ovarian Cancer Treatment: Insights from ASCO 2024

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.